Posted on 7/12/2021
DECEMBER 02, 2021 – Worthing, United Kingdom. Rayner Surgical Group (‘Rayner’) and Omeros Corporation (‘Omeros’) are delighted to announce the transfer of Omeros’ ophthalmology assets, including OmidriaTM, to Rayner. This will enable the creation of a significant commercial, regulatory and marketing infrastructure in the US, with a broad range of products, including intraocular lenses (IOLs), for cataract surgeons.
Industry Announcement: Winner of Queen’s Award for Enterprise 2020 (Innovation). Rayner RayOne Fully Preloaded IOL Injection System
Posted on 21/04/2020
Worthing (UK) – Rayner, the manufacturer of the world’s first Intraocular Lens (IOL), has been recognized for its excellence in innovation by winning the esteemed and internationally recognized Queen’s Award for Enterprise (QAE) for its RayOne fully preloaded IOL injection system, designed to create the smallest fully preloaded IOL incision during cataract surgery. Now in
First Implantation of RayOne Aspheric Fully Preloaded IOL in United States Completed by Renowned Surgeon William F. Wiley, MD
Posted on 6/02/2019
NEW YORK, New York, February 01, 2019 – The first U.S. implantation of Rayner’s flagship RayOne Aspheric fully preloaded monofocal IOL (RAO600C) was successfully performed by William F. Wiley, MD at the Brecksville Surgery Center in Cleveland, Ohio following FDA approval in late 2018.